Skip to Main Content

Advertisement

Close

AACR Journals
For Authors
About Us
Article Collections
COVID-19
Webinars

header search

search input Search input auto suggest

Search

Advanced Search

Menu

About
Articles
For Authors
Alerts
News
COVID-19
Webinars

Skip Nav Destination

Issues

Select Year

Issue

Volume 4, Issue 11

1 November 1998

Front Matter
Table of Contents
Back Matter
Editorial Board

ISSN 1078-0432

EISSN 1557-3265

Issue Sections

Editorial
Advances in Brief
Research Articles

Editorial

Therapeutic innovation: the up-front window.

E Frei, 3rd

Advances in Brief

Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.

W M Lin; E Forgacs; D P Warshal; I T Yeh; J S Martin; R Ashfaq; C Y Muller

Association between cyclin D1 (CCND1) gene amplification and human papillomavirus infection in human laryngeal squamous cell carcinoma.

P Cattani; S Hohaus; A Bellacosa; M Genuardi; S Cavallo; V Rovella; G Almadori; G Cadoni; J Galli; M Maurizi; G Fadda; G Neri

Research Articles

Metabolic and hemodynamic evaluation of brain metastases from small cell lung cancer with positron emission tomography.

U Lassen; P Andersen; G Daugaard; S Holm; M Jensen; C Svarer; H S Poulsen; O B Paulson

Phase II clinical trial of bolus infusion anti-B4 blocked ricin immunoconjugate in patients with relapsed B-cell non-Hodgkin's lymphoma.

P S Multani; S O'Day; L M Nadler; M L Grossbard

Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.

T Utsunomiya; S Yonezawa; H Sakamoto; H Kitamura; S Hokita; T Aiko; S Tanaka; T Irimura; Y S Kim; E Sato

Expression of p21WAF1 predicts outcome of esophageal cancer patients treated by surgery alone or by combined therapy modalities.

M Sarbia; M Stahl; A zur Hausen; K Zimmermann; L Wang; U Fink; H Heep; P Dutkowski; R Willers; W Müller; S Seeber; H E Gabbert

Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer.

G Gasparini; P C Brooks; E Biganzoli; P B Vermeulen; E Bonoldi; L Y Dirix; G Ranieri; R Miceli; D A Cheresh

Antagonistic effects of systemic interleukin 2 on immune Tcell-mediated graft-versus-leukemia reactivity.

V Schirrmacher; S Müerköster; V Umansky

Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect.

K Reiss; C D'Ambrosio; X Tu; C Tu; R Baserga

Alpha-cyano-beta-hydroxy-beta-methyl-N-[4-(trifluoromethoxy)phenyl] propenamide: an inhibitor of the epidermal growth factor receptor tyrosine kinase with potent cytotoxic activity against breast cancer cells.

S Ghosh; Y Zheng; X Jun; R K Narla; S Mahajan; C Navara; C Mao; E A Sudbeck; F M Uckun

Selection of tumor antigens as targets for immune attack using immunohistochemistry: protein antigens.

S Zhang; H S Zhang; C Cordon-Cardo; G Ragupathi; P O Livingston

A phase II "window" study of topotecan in untreated patients with high risk adult acute lymphoblastic leukemia.

S D Gore; E K Rowinsky; C B Miller; C Griffin; T L Chen; M Borowitz; R C Donehower; K L Burks; D K Armstrong; P J Burke; M R Grever; S H Kaufmann

Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma.

F M Foss; A Raubitscheck; J L Mulshine; T A Fleisher; J C Reynolds; C H Paik; R D Neumann; C Boland; P Perentesis; M R Brown; J M Frincke; C P Lollo; S M Larson; J A Carrasquillo

Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors.

A Korfel; M E Scheulen; H J Schmoll; O Gründel; A Harstrick; M Knoche; L M Fels; M Skorzec; F Bach; J Baumgart; G Sass; S Seeber; E Thiel; W E Berdel

Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.

D Choi; M Perrin; S Hoffmann; A E Chang; V Ratanatharathorn; J Uberti; K T McDonagh; J J Mulé

Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer.

Z Rahman; J Kavanagh; R Champlin; R Giles; E Hanania; S Fu; Z Zu; R Mehra; F Holmes; A Kudelka; D Claxton; C Verschraegen; J Gajewski; M Andreeff; S Heimfeld; R Berenson; D Ellerson; L Calvert; E Mechetner; T Holzmayer; A Dayne; J Hamer; C Bachier; J Ostrove; A Deisseroth

Superiority of sequential versus concurrent administration of paclitaxel with etoposide in advanced non-small cell lung cancer: comparison of two Phase II trials.

E Felip; B Massuti; C Camps; D Benito; D Isla; J L González-Larriba; M P López-Cabrerizo; O Salamanca; J Puerto-Pica; A Moyano; J Baselga; R Rosell

Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma.

C R Divgi; N H Bander; A M Scott; J A O'Donoghue; G Sgouros; S Welt; R D Finn; F Morrissey; P Capitelli; J M Williams; D Deland; A Nakhre; E Oosterwijk; S Gulec; M C Graham; S M Larson; L J Old

Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study.

S W Taber; V H Fingar; C T Coots; T J Wieman

Irinotecan (CPT-11) metabolism and disposition in cancer patients.

A Sparreboom; M J de Jonge; P de Bruijn; E Brouwer; K Nooter; W J Loos; R J van Alphen; R H Mathijssen; G Stoter; J Verweij

A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors.

J Cassidy; L Dirix; D Bissett; B Reigner; T Griffin; D Allman; B Osterwalder; A T Van Oosterom

A Phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution aminosyn in patients with advanced solid malignancies.

M Hidalgo; G Rodriguez; J G Kuhn; T Brown; G Weiss; J P MacGovren; D D Von Hoff; E K Rowinsky

Elevated serum levels of Trichosanthes japonica agglutinin-I binding alkaline phosphatase in relation to high-risk groups for hepatocellular carcinomas.

K Fukushima; T Hada; K Higashino; K Yamashita

Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.

H B Salvesen; O E Iversen; L A Akslen

Loss of heterozygosity at 11q23 in squamous cell carcinoma of the head and neck is associated with recurrent disease.

A D Lazar; M R Winter; C P Nogueira; P S Larson; E M Finnemore; R W Dolan; N Fuleihan; A Chakravarti; A Zietman; C L Rosenberg

High tumor angiogenesis is associated with poorer survival in carcinoma of the cervix treated with radiotherapy.

R A Cooper; D P Wilks; J P Logue; S E Davidson; R D Hunter; S A Roberts; C M West

Detection of microscopic neuroblastoma in marrow by histology, immunocytology, and reverse transcription-PCR of multiple molecular markers.

I Y Cheung; D Barber; N K Cheung

Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer.

H Ito; S Kyo; T Kanaya; M Takakura; K Koshida; M Namiki; M Inoue

Cytotoxicity and DNA fragmentation associated with sequential gemcitabine and 5-fluoro-2'-deoxyuridine in HT-29 colon cancer cells.

Q Ren; V Kao; J L Grem

DNA vaccination with HuD inhibits growth of a neuroblastoma in mice.

A F Carpentier; M R Rosenfeld; J Y Delattre; R G Whalen; J B Posner; J Dalmau

A single-chain immunotoxin against carcinoembryonic antigen that suppresses growth of colorectal carcinoma cells.

Y Akamatsu; J C Murphy; K F Nolan; P Thomas; R J Kreitman; S O Leung; R P Junghans

Improved efficacy and enlarged spectrum of activity of a novel anthracycline disaccharide analogue of doxorubicin against human tumor xenografts.

G Pratesi; M De Cesare; C Caserini; P Perego; L Dal Bo; D Polizzi; R Supino; M Bigioni; S Manzini; E Iafrate; C Salvatore; A Casazza; F Arcamone; F Zunino

Inhibition of apoptosis after thymineless stress is conferred by oncogenic K-Ras in colon carcinoma cells.

J A Houghton; R Ebanks; F G Harwood; D M Tillman

Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo.

P A Bunn, Jr; B A Helfrich; D G Brenner; D C Chan; D J Dykes; A J Cohen; Y E Miller

Antileukemia activity of a natural killer cell line against human leukemias.

Y Yan; P Steinherz; H G Klingemann; D Dennig; B H Childs; J McGuirk; R J O'Reilly

Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1alpha,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalcifero l (Ro 25-6760), on a human colon cancer xenograft.

S R Evans; A M Schwartz; E I Shchepotin; M Uskokovic; I B Shchepotin

Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts.

J A Bennett; S Zhu; A Pagano-Mirarchi; T A Kellom; H I Jacobson

Flavopiridol mediates cell cycle arrest and apoptosis in esophageal cancer cells.

D S Schrump; W Matthews; G A Chen; A Mixon; N K Altorki

Pharmacokinetics of O6-benzylguanine and its active metabolite 8-oxo-O6-benzylguanine in plasma and cerebrospinal fluid after intrathecal administration of O6-benzylguanine in the nonhuman primate.

S L Berg; D J Murry; C L McCully; K Godwin; F M Balis

Dipyridamole potentiates antipurine antifolate activity in the presence of hypoxanthine in tumor cells but not in normal tissues in vitro.

E Marshman; D R Newell; A H Calvert; A M Dickinson; H R Patel; F C Campbell; N J Curtin

Polynucleotide immunization of nonhuman primates against carcinoembryonic antigen.

R M Conry; S A White; P N Fultz; M B Khazaeli; T V Strong; K O Allen; D L Barlow; S E Moore; P N Coan; I Davis; D T Curiel; A F LoBuglio

Bcl-2 but not Bax expression is associated with apoptosis in normal and transformed squamous epithelium.

S D Drenning; A J Marcovitch; D E Johnson; M F Melhem; D J Tweardy; J R Grandis

Advertisement

Email alerts

Online First Alert

eTOC Alert

Latest
Most Read
Most Cited

Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas

Biology and Targetability of the Extended Spectrum of PIK3CA Mutations Detected in Breast Carcinoma

T cell receptor repertoire sequencing in the era of cancer immunotherapy

HER2 copy number and resistance mechanisms in patients with HER2-positive advanced gastric cancer receiving initial trastuzumab-based therapy in JACOB trial

Issues
Online First
Collections

News
Twitter

Online ISSN 1557-3265
Print ISSN 1078-0432

AACR Journals

Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers, & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics

Info for Advertisers
Info for Librarians
Privacy Policy

Twitter
LinkedIn
Facebook
Youtube

Copyright © 2022 by the American Association for Cancer Research.

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.

Accept